Edward van Wezel
InvestorManaging Partner at BioGeneration Ventures
Naarden, Netherlands
Writes $100K – $1M checks · typically $500K
FoundedLink Immunotherapeutics
Experience
- Epsilogen LtdBoard Observercurrent2025 — present
- Libertatis Ergo Holding B.V.Board Directorcurrent2024 — presentLeiden, South Holland, Netherlands
- Kivu BioscienceBoard Directorcurrent2023 — presentSan Mateo, California, United States
- BGV (BioGeneration Ventures)Founder and Managing Partnercurrent2006 — present
- Confo TherapeuticsBoard Directorcurrent2019 — presentBelgium
- Scenic BiotechBoard Directorcurrent2017 — presentAmsterdam, Netherlands
- AZAFAROS B.V.Board Director / Board Observercurrent2018 — presentLeiden, Netherlands
- Mibiton FoundationBoard Member2016 — 2026
- TigaTxDirector2020 — 2025
- Acerta Pharma B.V.Founding investor and member of the supervisory board2013 — 2016Oss, Netherlands
- Macrozyme BVManaging Director2001 — 2005
- Johnson & JohnsonProject Manager1997 — 2000
Education
- Utrecht UniversityChemistry
- Delft University of TechnologyBiochemical process technology
Deals · 1
Link ImmunotherapeuticsBoard seat
via BioGeneration Ventures · filed Apr 2021 · $17.3M raise
Attribution from SEC filings, press coverage, and firm rosters.
Colleagues at BioGeneration Ventures
Alexander Vos
Venture Partner at BioGeneration Ventures
Andree Blaukat
Senior Advisor at BioGeneration Ventures
Arnon Kater
Senior Advisor at BioGeneration Ventures
Arnoud Dijkstra
Venture Partner at BioGeneration Ventures
Claire van Viersen
Executive Assistant at BioGeneration Ventures
Cyril Lesser
Vice President Finance | Funds at BioGeneration Ventures
Daniela Couto
General Partner at BioGeneration Ventures
Diede Brunen
Principal at BioGeneration Ventures
Network5
Alexander Vos
Venture Partner at BioGeneration Ventures
Arnoud Dijkstra
Venture Partner at BioGeneration Ventures
Daniela Couto
General Partner at BioGeneration Ventures
Diede Brunen
Principal at BioGeneration Ventures
Joost Holthuis
Venture Partner at BioGeneration Ventures
Investors connected to Edward in public investor directories — a warm-intro map.
Frequently asked questions
- Where does Edward van Wezel work?
- Edward van Wezel is Managing Partner at BioGeneration Ventures.
- What check size does Edward van Wezel write?
- Edward van Wezel typically writes checks of $100K – $1M.
- What companies did Edward van Wezel found?
- Edward van Wezel founded Link Immunotherapeutics.
Same school
Also attended Utrecht University86
Matthijs BlokhuisDirecteur at NoaberRoel DekkersInvestment manager at NoaberIrene KrijgsmanProgramma manager at NoaberMarlene van LooProgramma manager at NoaberRuben OsnabruggePartner & Chief Medical Officer at 415 CapitalDr. Benedikt BuchspiesPrincipal - Technology Research and Science at Planet A Ventures
+ 80 more
Also attended Delft University of Technology138
Michiel KottingPartner at NorthzoneGiuseppe LacerenzaPartner at Keen Venture PartnersAlexander WortmannPartner at TCVThijs SchaapInvestment manager at NoaberHugo SilvaPartner at Pi LabsRobInvestor at henQ vc
+ 132 more
Shared employers
Also worked at Kivu Bioscience1
Also worked at Confo Therapeutics4
Also worked at Scenic Biotech9
Alexandra (Sandra) GlucksmannAdvisory Partner at Adjuvant CapitalMichael WackerManaging Partner at BioMedPartnersThijs Cohen TervaertPartner at InkefSimone BottiSenior Partner at InkefAndrew McLeanManaging Partner at Tin Alley VenturesAlexander VosVenture Partner at BioGeneration Ventures
+ 3 more
